Back
Silgan Holdings 10K Form
Sell
47
SLGN
Silgan Holdings
Last Price:
$55.36
Seasonality Move:
0.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-11-02 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-08-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-05-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-11-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-08-04 | 10Q | SLGN/Silgan Holdings Quarterly |
Receive SLGN News And Ratings
See the #1 stock for the next 7 days that we like better than SLGN
SLGN Financial Statistics
Sales & Book Value
Annual Sales: | $5.9B |
---|---|
Cash Flow: | $-766.3M |
Price / Cash Flow: | 18.83 |
Annual Sales: | $19.47 |
Price / Book: | 2.85 |
Profitability
EPS (TTM): | 2.69000 |
---|---|
Net Income (TTM): | $289.2M |
Gross Margin: | $1B |
Return on Equity: | 14.52% |
Return on Assets: | 3.58% |
Silgan Holdings Earnings Forecast
Key Silgan Holdings Financial Ratios
-
The Gross Profit Margin over the past 31 years for SLGN is 17.28%.
-
The Selling, General & Administrative Expenses for SLGN have been equal to 7.47% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 60.20% of Operating Income.
-
The Net Earning history of SLGN is 4.72% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 16 years.
Silgan Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | SLGN |
CUSIP: | 827048 |
Website: | silganholdings.com |
Debt
Debt-to-Equity Ratio: | 2.22 |
---|---|
Current Ratio: | 1.14 |
Quick Ratio: | 0.6 |
Price-to-Earnings
Trailing P/E Ratio: | 21.51 |
---|---|
Forward P/E Ratio: | 12.38 |
SLGN Technical Analysis vs Fundamental Analysis
Sell
47
Silgan Holdings (SLGN)
is a Sell
Is Silgan Holdings a Buy or a Sell?
-
Silgan Holdings stock is rated a SellThe current Silgan Holdings [SLGN] share price is $55.49. The Score for SLGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.